Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001209191-20-064665

Options or other derivatives

  • President and CMO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rakhit Amit President and CMO 2020-12-17 Grant or award · Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…